Purchases and Sales Made in Q4 2024 in Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL) during Q4 2024. The information is specifically focused on institutions that hold shares of AbCellera Biologics Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 13, 2025
Q4 2024
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-100K- 86.97% |
$248K - $315K
|
15K
$60.4K
|
|
Jan 13, 2025
Q4 2024
|
Salem Investment Counselors Inc
Winston Salem, NC |
SELL
|
- |
-118K- 61.47% |
$291K - $370K
|
73.7K
$297K
|
|
Feb 13, 2025
Q4 2024
|
Td Waterhouse Canada Inc.
Toronto, A6 |
SELL
|
- |
-128K- 55.0% |
$317K - $403K
|
105K
$422K
|
|
Feb 14, 2025
Q4 2024
|
Lazard Asset Management LLC
New York, NY |
SELL
|
- |
-168K- 15.32% |
$417K - $529K
|
929K
$3.74M
|
|
Feb 13, 2025
Q4 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-242K- 94.16% |
$600K - $762K
|
15K
$60.5K
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-460K- 15.6% |
$1.14M - $1.45M
|
2.49M
$10M
|
|
Jan 31, 2025
Q4 2024
|
Baillie Gifford & CO
|
SELL
|
- |
-658K- 5.1% |
$1.63M - $2.07M
|
12.2M
$49.3M
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-902K- 60.17% |
$2.24M - $2.84M
|
597K
$2.41M
|
|
Feb 13, 2025
Q4 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-1.37M- 59.86% |
$3.39M - $4.3M
|
916K
$3.69M
|
|
Feb 14, 2025
Q4 2024
|
Prosight Management, LP
Dallas, TX |
SELL
|
- |
-1.73M- 19.05% |
$4.29M - $5.45M
|
7.35M
$29.6M
|